AIM ImmunoTech, Inc. (AIM)

0.4011 +0.17 (+72.37%) USD  |  NYAM  |  May 27, 16:00
0.3382 -0.06 (-15.68%) After-Hours: 06:15
More

AIM ImmunoTech Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. --
Halozyme Therapeutics, Inc. Upgrade